Cargando…

Insight into the Development of PET Radiopharmaceuticals for Oncology

While the development of positron emission tomography (PET) radiopharmaceuticals closely follows that of traditional drug development, there are several key considerations in the chemical and radiochemical synthesis, preclinical assessment, and clinical translation of PET radiotracers. As such, we o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lau, Joseph, Rousseau, Etienne, Kwon, Daniel, Lin, Kuo-Shyan, Bénard, François, Chen, Xiaoyuan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7281377/ https://www.ncbi.nlm.nih.gov/pubmed/32455729 http://dx.doi.org/10.3390/cancers12051312

Ejemplares similares

PET Oncological Radiopharmaceuticals: Current Status and Perspectives
por: Lin, Mai, et al.
Publicado: (2022)

A Systematic Review of Molecular Imaging Agents Targeting Bradykinin B1 and B2 Receptors
por: Lau, Joseph, et al.
Publicado: (2020)

Development and Validation of a PET/SPECT Radiopharmaceutical in Oncology
por: Pisaneschi, Federica, et al.
Publicado: (2021)

Past, Present, and Future: Development of Theranostic Agents Targeting Carbonic Anhydrase IX
por: Lau, Joseph, et al.
Publicado: (2017)

Development of Antibody Immuno-PET/SPECT Radiopharmaceuticals for Imaging of Oncological Disorders—An Update
por: Dewulf, Jonatan, et al.
Publicado: (2020)

Application of Cleavable Linkers to Improve Therapeutic Index of Radioligand Therapies
por: Lau, Joseph, et al.
Publicado: (2022)

Recent Developments in PET and SPECT Radiotracers as Radiopharmaceuticals for Hypoxia Tumors
por: Nguyen, Anh Thu, et al.
Publicado: (2023)

PET Radiopharmaceuticals
por: Shahhosseini, Soraya
Publicado: (2011)

Molecular imaging in oncology: Common PET/CT radiopharmaceuticals and applications()
por: Franquet, Elisa, et al.
Publicado: (2022)

Positron Emission Tomography Imaging of the Gastrin-Releasing Peptide Receptor with a Novel Bombesin Analogue
por: Lau, Joseph, et al.
Publicado: (2019)

Reducing the Kidney Uptake of High Contrast CXCR4 PET Imaging Agents via Linker Modifications
por: Kwon, Daniel, et al.
Publicado: (2022)

Update on PET Radiopharmaceuticals for Imaging Hepatocellular Carcinoma
por: Nyakale, Nozipho, et al.
Publicado: (2023)

Innovative radiopharmaceuticals in oncology and neurology
por: Kraeber-Bodéré, Françoise, et al.
Publicado: (2017)

Design, synthesis and evaluation of (18)F-labeled cationic carbonic anhydrase IX inhibitors for PET imaging
por: Zhang, Zhengxing, et al.
Publicado: (2017)

Positron Emission Tomography (PET) Radiopharmaceuticals in Multiple Myeloma
por: Sachpekidis, Christos, et al.
Publicado: (2019)

Paget Disease as Common Pitfall on PET with Different Radiopharmaceuticals in Oncology: Not All That Glitters Is Gold!
por: Dondi, Francesco, et al.
Publicado: (2022)

Monosodium Glutamate Reduces (68)Ga-PSMA-11 Uptake in Salivary Glands and Kidneys in a Preclinical Prostate Cancer Model
por: Rousseau, Etienne, et al.
Publicado: (2018)

Editorial: Innovative Radiopharmaceuticals in Oncology and Neurology
por: Barbet, Jacques, et al.
Publicado: (2017)

Will extended field-of-view PET/CT depopulate the graveyard of failed PET radiopharmaceuticals?
por: de Vries, E. F. J., et al.
Publicado: (2022)

Rhenium-188 Labeled Radiopharmaceuticals: Current Clinical Applications in Oncology and Promising Perspectives
por: Lepareur, Nicolas, et al.
Publicado: (2019)

New SPECT and PET Radiopharmaceuticals for Imaging Cardiovascular Disease
por: Sogbein, Oyebola O., et al.
Publicado: (2014)

PET Radiopharmaceuticals for Imaging Integrin Expression: Tracers in Clinical Studies and Recent Developments
por: Haubner, Roland, et al.
Publicado: (2014)

Radiopharmaceuticals for PET imaging: issue A
por: Roivainen, Anne, et al.
Publicado: (2020)

Methods to Enhance the Metabolic Stability of Peptide-Based PET Radiopharmaceuticals
por: Evans, Brendan J., et al.
Publicado: (2020)

PET Radiopharmaceuticals for Specific Bacteria Imaging: A Systematic Review
por: Auletta, Sveva, et al.
Publicado: (2019)

Radiopharmaceuticals in Nuclear Medicine: Recent Developments for SPECT and PET Studies
por: Gutfilen, Bianca, et al.
Publicado: (2014)

Development of Folate Receptor−Targeted PET Radiopharmaceuticals for Tumor Imaging—A Bench-to-Bedside Journey
por: Boss, Silvan D., et al.
Publicado: (2020)

Molecular Imaging and Radionuclide Therapy of Melanoma Targeting the Melanocortin 1 Receptor
por: Zhang, Chengcheng, et al.
Publicado: (2017)

SPECT and PET radiopharmaceuticals for molecular imaging of apoptosis: from bench to clinic
por: Wang, Xiaobo, et al.
Publicado: (2017)

Intracranial Solitary Fibrous Tumor: A “New” Challenge for PET Radiopharmaceuticals
por: Sardaro, Angela, et al.
Publicado: (2022)

SPECT/CT and PET/CT, related radiopharmaceuticals, and areas of application and comparison
por: Alqahtani, Fawaz F.
Publicado: (2023)

PET Radiopharmaceuticals for Imaging Chemotherapy-Induced Cardiotoxicity
por: Sivapackiam, Jothilingam, et al.
Publicado: (2020)

Pharmacokinetics, radiation dosimetry, acute toxicity and automated synthesis of [(18)F]AmBF(3)-TATE
por: Lau, Joseph, et al.
Publicado: (2020)

Prospective of (68)Ga-Radiopharmaceutical Development
por: Velikyan, Irina
Publicado: (2013)

Prospects for Radiopharmaceuticals as Effective and Safe Therapeutics in Oncology and Challenges of Tumor Resistance to Radiotherapy
por: Nikolova, Ekaterina, et al.
Publicado: (2021)

PET Radiopharmaceuticals for Alzheimer’s Disease and Parkinson’s Disease Diagnosis, the Current and Future Landscape
por: Uzuegbunam, Bright Chukwunwike, et al.
Publicado: (2020)

Hydroxypyridinone Chelators: From Iron Scavenging to Radiopharmaceuticals for PET Imaging with Gallium-68
por: Cusnir, Ruslan, et al.
Publicado: (2017)

PET with Different Radiopharmaceuticals in Neuroendocrine Neoplasms: An Umbrella Review of Published Meta-Analyses
por: Treglia, Giorgio, et al.
Publicado: (2021)

Radiopharmaceuticals for PET and SPECT Imaging: A Literature Review over the Last Decade
por: Crișan, George, et al.
Publicado: (2022)

FDG and Non-FDG Radiopharmaceuticals for PET Imaging in Invasive Lobular Breast Carcinoma
por: Gilardi, Laura, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_g332f8d14sdhgh6bfqns26ou0h